Mar Valés-Gómez Selected Research

NK Cell Lectin-Like Receptor Subfamily K

1/2024	Elevated levels of cell-free NKG2D-ligands modulate NKG2D surface expression and compromise NK cell function in severe COVID-19 disease.
1/2023	NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cells.
5/2018	Immunoassays for scarce tumour-antigens in exosomes: detection of the human NKG2D-Ligand, MICA, in tetraspanin-containing nanovesicles from melanoma.
1/2016	Glycosyl-Phosphatidyl-Inositol (GPI)-Anchors and Metalloproteases: Their Roles in the Regulation of Exosome Composition and NKG2D-Mediated Immune Recognition.
8/2014	Altered microRNA expression after infection with human cytomegalovirus leads to TIMP3 downregulation and increased shedding of metalloprotease substrates, including MICA.
1/2012	Human NKG2D-ligands: cell biology strategies to ensure immune recognition.
1/2010	Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes.
3/2008	Selective induction of expression of a ligand for the NKG2D receptor by proteasome inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mar Valés-Gómez Research Topics

Disease

17	Neoplasms (Cancer) 10/2023 - 03/2008
7	Urinary Bladder Neoplasms (Bladder Cancer) 10/2023 - 01/2015
4	Non-Muscle Invasive Bladder Neoplasms 01/2023 - 01/2017
4	Melanoma (Melanoma, Malignant) 01/2022 - 01/2018
4	Infections 11/2021 - 08/2014
3	COVID-19 01/2022 - 12/2020
2	Critical Illness (Critically Ill) 01/2024 - 01/2024
2	Carcinoma (Carcinomatosis) 01/2019 - 01/2015
1	Asymptomatic Infections 01/2024
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2023
1	Leukemia 01/2023
1	Lung Neoplasms (Lung Cancer) 02/2022
1	Uniparental Disomy 01/2018
1	Virus Diseases (Viral Diseases) 12/2017
1	Lymphopenia (Lymphocytopenia) 01/2017
1	Carcinoma in Situ 01/2015
1	Hematologic Neoplasms (Hematological Malignancy) 03/2008

Drug/Important Bio-Agent (IBA)

13	LigandsIBA 01/2024 - 03/2008
8	NK Cell Lectin-Like Receptor Subfamily KIBA 01/2024 - 03/2008
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2018
5	micaIBA 01/2021 - 01/2010
4	AntigensIBA 01/2024 - 05/2018
4	CytokinesIBA 01/2023 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
2	AntibodiesIBA 01/2024 - 11/2021
2	Epithelial Cell Adhesion MoleculeIBA 02/2022 - 01/2019
2	TetraspaninsIBA 01/2021 - 05/2018
2	ChemokinesIBA 07/2019 - 01/2017
1	Fc Receptors (Fc Receptor)IBA 01/2024
1	SARS-CoV-2 membrane proteinIBA 01/2024
1	Immune Checkpoint InhibitorsIBA 10/2023
1	Tuberculosis VaccinesIBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Melanoma-Specific AntigensIBA 01/2022
1	Viral AntigensIBA 11/2021
1	Interleukin-15 (Interleukin 15)IBA 01/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Natural Killer Cell ReceptorsIBA 01/2021
1	Immunoglobulin M (IgM)IBA 12/2020
1	Monoclonal AntibodiesIBA 12/2020
1	Peptide Hydrolases (Proteases)FDA Link 12/2020
1	Immunoglobulin A (IgA)IBA 12/2020
1	Immunoglobulin G (IgG)IBA 12/2020
1	Chemotactic FactorsIBA 07/2019
1	EpitopesIBA 05/2018
1	Interferon Regulatory FactorsIBA 01/2018
1	NectinsIBA 01/2018
1	VemurafenibIBA 01/2018
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2018
1	Butyric Acid (Butanoic Acid)IBA 01/2018
1	Histone Deacetylase InhibitorsIBA 01/2018
1	InterferonsIBA 12/2017
1	Pattern Recognition ReceptorsIBA 12/2017
1	Carrier Proteins (Binding Protein)IBA 12/2017
1	Double-Stranded RNA (RNA, Double Stranded)IBA 12/2017
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2017
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2017
1	Metalloproteases (Metalloproteinases)IBA 08/2014
1	MicroRNAs (MicroRNA)IBA 08/2014
1	Proteasome InhibitorsIBA 03/2008

Therapy/Procedure

6	Therapeutics 01/2021 - 03/2008
4	Immunotherapy 10/2023 - 01/2017
3	Intravesical Administration 10/2023 - 01/2015